SOPHiA GENETICS SA (SOPH)
Healthcare
Health Information Services
5.70 $
-1.6%
vs. previous close
Closing price · As of: 31. Jul 2026
SOPHiA GENETICS SA (SOPH) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -38 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| -32 | -32 | -58 | -70 | -49 | -43 | -38 | |
| 1.9 | 2.4 | 3.6 | 5.6 | 8.3 | 8.6 | 9.5 | |
| 0.7 | 1.4 | 8.5 | 14 | 15 | 16 | 16 | |
| 1.8 | 1.4 | 6.0 | 13 | – | – | – | |
| -1.6 | 3.8 | 6.1 | -1.3 | 0.9 | -2.6 | 11 | |
| 3.0 | 3.2 | 6.7 | 10 | 9.2 | 8.2 | 0.6 | |
| -3.0 | -24 | -57 | 42 | 8.3 | -8.2 | -11 | |
| – | – | – | – | 0.0 | 0.0 | 0.0 | |
| -2.8 | -1.7 | -4.1 | -2.3 | -3.0 | 11 | 33 | |
| -1.0 | 107 | 238 | -1.6 | -2.8 | 12 | 34 | |
| -36 | 57 | 118 | -32 | -38 | -43 | -9.9 | |
| -35 | -35 | -65 | -80 | -58 | -51 | -39 |
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.